Literature DB >> 11405197

Evidence-based medicine (EBM) in the treatment of hypertension in older patients.

S Teramoto, H Kume, T Matsuse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11405197      PMCID： PMC1495208          DOI： 10.1046/j.1525-1497.2001.10219-3.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  7 in total

1.  ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives.

Authors:  S Teramoto; Y Ouchi
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

2.  Evidence-based medicine: worship of form and treatment of high blood pressure.

Authors:  B M Psaty; C Rhoads; C D Furberg
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

3.  Effects of angiotensin-converting enzyme inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease.

Authors:  S Teramoto; M Suzuki; T Matsuse; T Ishii; Y Fukuchi; Y Ouchi
Journal:  Jpn J Pharmacol       Date:  2000-05

4.  Calcium-channel blockade and incidence of cancer in aged populations.

Authors:  M Pahor; J M Guralnik; L Ferrucci; M C Corti; M E Salive; J R Cerhan; R B Wallace; R J Havlik
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

5.  Failure of evidence-based medicine in the treatment of hypertension in older patients.

Authors:  E L Knight; R J Glynn; R Levin; D A Ganz; J Avorn
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

6.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

Authors:  C D Furberg; B M Psaty; J V Meyer
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

7.  Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

Authors:  M Pahor; J M Guralnik; C D Furberg; P Carbonin; R Havlik
Journal:  Lancet       Date:  1996-04-20       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.